# Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction

> **NCT06021587** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 300 (estimated)

## Conditions studied

- Levosimendan
- Cardiac Surgery
- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** No Levosimendan

## Key facts

- **NCT ID:** NCT06021587
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2023-07-02
- **Final completion:** 2023-10-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021587, "Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06021587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*